Work

CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib

Year: 2018

Type: article

Source: Leukemia

DOI: 10.1038/s41375-018-0009-0

Authors: Hardikkumar Jetani, Irene Garcia-Cadenas, Thomas Nerreter, Simone Thomas, Julian Rydzek, Javier Briones Meijide, Halvard Bonig, Wolfgang Herr, Jordi Sierra, Hermann Einsele, Michael Hudecek

Institutions: Universitätsklinikum Würzburg, Universitat Autònoma de Barcelona, Hospital de Sant Pau, Josep Carreras Leukaemia Research Institute, University Hospital Regensburg, Goethe University Frankfurt, German Red Cross

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2791898577

FWCI: 9.021

Cites: 52

Cited by: 204

Related to: 10